By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Precision BioSciences today announced that it has filed two more patent infringement lawsuits against French firm Cellectis.

The lawsuits were filed in US District Court for the Eastern District of North Carolina and allege Cellectis infringes US Patent Nos. 8,119,381 and 8,119,361. The patents relate to Precision Bio's Directed Nuclease Editor genome engineering technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.